LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 10.91%548.26M | -6.74%148.23M | 30.75%131.04M | 50.58%142.54M | -10.01%126.46M | -8.83%494.34M | 27.38%158.94M | -28.31%100.22M | -21.25%94.66M | -10.76%140.52M |
Net income from continuing operations | -13.76%291.29M | -19.46%87.72M | -19.05%55.39M | -6.81%69.81M | -8.37%78.37M | -13.47%337.78M | -36.01%108.92M | -28.32%68.42M | 130.93%74.91M | -7.28%85.53M |
Operating gains losses | --2.77M | ---11.95M | --9.7M | --585K | --4.43M | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 41.18%187.11M | 33.17%48.16M | 45.60%47.37M | 42.66%46.7M | 44.31%44.87M | 3.25%132.54M | 16.46%36.17M | 5.67%32.54M | -1.08%32.74M | -6.97%31.1M |
Deferred tax | -125.54%-9.16M | -110.69%-3.97M | 2,037.10%2.4M | -1,630.82%-7.58M | 98.60%-10K | 200.13%35.86M | 331.61%37.14M | 98.21%-124K | -110.53%-438K | -111.65%-712K |
Other non cash items | -6.73%10.54M | 23.55%3.43M | 9.74%2.91M | -68.64%1.18M | 42.81%3.03M | 32.68%11.3M | 98.64%2.77M | 39.86%2.65M | 46.26%3.76M | -20.20%2.12M |
Change In working capital | 949.62%33.63M | 121.13%17.27M | 174.10%6.64M | 201.35%19.86M | -160.42%-10.14M | 63.95%-3.96M | 155.95%7.81M | -146.29%-8.96M | 45.16%-19.6M | -13.23%16.79M |
-Change in receivables | 86.61%-2.45M | -111.44%-1.72M | 108.84%3.12M | -235.70%-3.18M | -47.78%-665K | -334.68%-18.3M | 354.90%15.06M | -943.94%-35.25M | -27.02%2.34M | -124.10%-450K |
-Change in inventory | 125.00%1.99M | 529.52%14.95M | -67.67%-4.33M | 69.31%-697K | -44.47%-7.94M | -27.02%-7.97M | -67.61%2.38M | -134.47%-2.58M | 88.17%-2.27M | -189.11%-5.49M |
-Change in payables and accrued expense | -50.07%18.35M | -131.11%-3.97M | -71.26%7.43M | 265.77%22.67M | -165.75%-7.78M | 7,540.08%36.75M | 182.99%12.76M | 69.37%25.84M | 30.75%-13.68M | -38.97%11.83M |
-Change in other working capital | 208.95%15.74M | 135.79%8.01M | -85.96%426K | 117.73%1.06M | -42.81%6.24M | ---14.44M | ---22.39M | --3.03M | ---5.99M | --10.9M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 10.91%548.26M | -6.74%148.23M | 30.75%131.04M | 50.58%142.54M | -10.01%126.46M | -8.83%494.34M | 27.38%158.94M | -28.31%100.22M | -21.25%94.66M | -10.76%140.52M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 50.78%-321.79M | 73.15%-35.79M | 26.01%-100.93M | 58.33%-85.08M | 44.44%-100M | -47.88%-653.85M | -84.45%-133.31M | 48.58%-136.4M | -216.62%-204.16M | -348.46%-179.97M |
Capital expenditure reported | 59.42%-283.87M | 85.64%-26.86M | 40.67%-80.34M | 61.02%-78.59M | 44.11%-98.08M | -112.88%-699.52M | -43.82%-187M | -39.32%-135.41M | -222.95%-201.61M | -350.63%-175.5M |
Net PPE purchase and sale | -610.20%-14.97M | --0 | ---13.03M | ---1.94M | --0 | 99.09%-2.11M | --0 | --0 | --0 | ---2.11M |
Net other investing changes | -148.04%-22.95M | -116.64%-8.93M | -664.31%-7.56M | -77.80%-4.55M | 19.08%-1.91M | -59.92%47.77M | -53.89%53.68M | -116.42%-989K | -24.36%-2.56M | -99.33%-2.36M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 50.78%-321.79M | 73.15%-35.79M | 26.01%-100.93M | 58.33%-85.08M | 44.44%-100M | -47.88%-653.85M | -84.45%-133.31M | 48.58%-136.4M | -216.62%-204.16M | -348.46%-179.97M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -211.05%-199.67M | -502.95%-65.55M | -184.48%-49.06M | -149.37%-50.72M | -215.00%-34.35M | 161.99%179.81M | 70.05%-10.87M | 295.45%58.07M | 161.16%102.75M | 153.29%29.87M |
Net issuance payments of debt | -73.42%89.75M | -263.06%-33.93M | -100.90%-850K | -104.49%-7M | 96.88%131.53M | 170.78%337.72M | -79.96%20.81M | 183.15%94.31M | 2,615.01%155.81M | 1,178.37%66.81M |
Net common stock issuance | ---3.92M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash dividends paid | -102.09%-118.4M | -1.59%-14.79M | -1.79%-14.76M | -1.94%-14.77M | -392.49%-74.09M | 49.78%-58.59M | 79.76%-14.56M | -0.40%-14.5M | 0.06%-14.49M | 4.72%-15.04M |
Net other financing activities | -68.24%-167.1M | 1.67%-16.83M | -53.86%-33.45M | 35.11%-25.03M | -319.22%-91.79M | 36.57%-99.32M | 74.89%-17.11M | 26.50%-21.74M | -14.75%-38.57M | 13.24%-21.9M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -211.05%-199.67M | -502.95%-65.55M | -184.48%-49.06M | -149.37%-50.72M | -215.00%-34.35M | 161.99%179.81M | 70.05%-10.87M | 295.45%58.07M | 161.16%102.75M | 153.29%29.87M |
Net cash flow | ||||||||||
Beginning cash position | 17.31%137.59M | -4.35%117.5M | 35.17%136.45M | 20.42%129.71M | 17.31%137.59M | -61.83%117.29M | 21.50%122.84M | -60.61%100.95M | -70.77%107.71M | -61.83%117.29M |
Current changes in cash | 32.02%26.8M | 217.86%46.89M | -186.60%-18.95M | 199.79%6.74M | 17.75%-7.88M | 110.68%20.3M | -8.91%14.75M | 114.10%21.89M | 93.98%-6.76M | -115.64%-9.58M |
End cash Position | 19.48%164.38M | 19.48%164.38M | -4.35%117.5M | 35.17%136.45M | 20.42%129.71M | 17.31%137.59M | 17.31%137.59M | 21.50%122.84M | -60.61%100.95M | -70.77%107.71M |
Free cash flow | 220.33%249.42M | 532.49%121.37M | 207.02%37.66M | 157.99%62.01M | 176.52%28.38M | -983.97%-207.29M | 56.10%-28.06M | 73.23%-35.19M | -285.13%-106.95M | -131.29%-37.09M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |